Search

Aim of the current research was examining the relation between the quality of work life components and four career anchors among the Personnel of Esfahan's Iron Foundry Organization. The data collection instruments were two researcher-made questionnaires about the quality of work life. The results show that among the eight components of the quality of work life, those which were most influential on the four career anchors were social integrity and attachment in the organization. Furthermore, it can be concluded that the quality of work life of this Iron Foundry personnel in each one of the career anchors is at an average level.

The current research has examined the effect of advanced organizers within web-based instruction on the learning and retention of concepts in chemistry courses. The research method is quasi-experimental with non-equivalent groups and using pre-test and post-test. The results showed that in terms of the level of learning, there was not a significant statistical difference between the students who received advanced organizer (experiment group) and those who did not receive it (control group); however, the amount of retention was significantly greater in the experiment group than in the control group.

Because of high neutron and gamma-ray intensities generated during bombardment of a thallium-203 target, a thallium target-room shield and different ways of improving it have been investigated. Leakage of neutron and gamma ray dose rates at various points behind the shield are calculated by simulating the transport of neutrons and photons using the Monte Carlo N Particle transport computer code. By considering target-room geometry, its associated shield and neutron and gamma ray source strengths and spectra, three designs for enhancing shield performance have been analysed: a shielding door at the maze entrance, covering maze walls with layers of some effective materials and adding a shadow-shield in the target room in front of the radiation source. Dose calculations were carried out separately for different materials and dimensions for all the shielding scenarios considered. The shadow-shield has been demonstrated to be one suitable for neutron and gamma dose equivalent reduction. A 7.5-cm thick polyethylene shadow-shield reduces both dose equivalent rate at maze entrance door and leakage from the shield by a factor of 3.

Context: Herceptin and its fragments have been radiolabeled and used in the imaging of human epidermal growth factor receptor 2 (HER2)/neu-positive tumors and development of diagnostic kits is of great importance in radiopharmacy. Aims: In this study, 111 In-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-trastuzumab ( 111 In-DOTA-trastuzumab) was successively prepared and evaluated for ultimate use in the HER2 antigen imaging in oncology. Settings and Design: The conjugate was prepared, labeled and evaluated using in vitro (radioimmunoassay [RIA], enzyme-linked immunosorbent assay (ELISA), stability, binding, internalization)/in vivo (bio-distribution, single-photon emission computed tomography [SPECT]) experiments. Materials and Methods: 111 In-DOTA-trastuzumab was prepared followed by determination of radiochemical purity (RCP), integrity of protein, immunoreactivity of radiolabeled antibody with HER2/neu antigen (by SkBr3 cell line binding and RIA methods) were determined followed by stability tests, internalization studies and the tissue bio-distribution determination in wild-type rats as well as SPECT imaging in SkBr3-bearing mice. Statistical Analysis Used: All values were expressed as mean ± standard deviation (mean ± SD) and the data were compared using Student′s t-test. Statistical significance was defined as P < 0.05. Results: 111 In-DOTA-trastuzumab was prepared (RCP >95 ± 0.5%, S.A. 5.3 μCi/μg) with the average number of chelators per antibody of 6:1 showing significant immune-reactivity retention using ELISA. In vitro stability was >90% in phosphate buffered saline and 80 ± 0.5% in serum over 48 h. Cell binding was significant (>0.79). In vitro internalization reached up to %12-13 in 10 h. Significant tumor uptake was observed. Conclusions: In vitro and in vivo/SPECT imaging in SkBr3-bearing mice demonstrated that 111 In-DOTA-trastuzumab is a potential compound for molecular imaging of SPECT for diagnosis and follow-up of HER2 expression in oncology.